Baseline characteristics and oxidative profiling. by Summan Thahiem (20988319)

Subjects:

Characteristics of the included studies. by Xin Liu (43569)

“…Subgroup analysis revealed that high-dose TXA significantly reduced intraoperative blood loss and transfusion rates in RCSs, whereas no significant differences were observed in RCTs. …”

Summary of results. by Xin Liu (43569)

“…Subgroup analysis revealed that high-dose TXA significantly reduced intraoperative blood loss and transfusion rates in RCSs, whereas no significant differences were observed in RCTs. …”

Bias risk assessments for each RCT study. by Xin Liu (43569)

“…Subgroup analysis revealed that high-dose TXA significantly reduced intraoperative blood loss and transfusion rates in RCSs, whereas no significant differences were observed in RCTs. …”

The flow chart of studies selecting. by Xin Liu (43569)

“…Subgroup analysis revealed that high-dose TXA significantly reduced intraoperative blood loss and transfusion rates in RCSs, whereas no significant differences were observed in RCTs. …”

Funnel plots for intraoperative blood loss. by Xin Liu (43569)

“…Subgroup analysis revealed that high-dose TXA significantly reduced intraoperative blood loss and transfusion rates in RCSs, whereas no significant differences were observed in RCTs. …”

Bias risk assessments for each RCS study. by Xin Liu (43569)

“…Subgroup analysis revealed that high-dose TXA significantly reduced intraoperative blood loss and transfusion rates in RCSs, whereas no significant differences were observed in RCTs. …”

Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

“…Standardized sleep hygiene education did not produce significant changes in sleep parameters. Our findings indicate fragmented nocturnal sleep in patients with MASLD, characterized by increased wakefulness and reduced sleep efficiency, perceived subjectively as shortened sleep duration and delayed onset. …”

Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

“…Standardized sleep hygiene education did not produce significant changes in sleep parameters. Our findings indicate fragmented nocturnal sleep in patients with MASLD, characterized by increased wakefulness and reduced sleep efficiency, perceived subjectively as shortened sleep duration and delayed onset. …”

Table 2 - by Rosanna Mary Rooney (17595801)

“…The review is expected to identify effective interventions that address critical factors within each domain, including Multisystemic Therapy (MST) and Multidimensional Treatment Foster Care (MTFC), which have shown promise in reducing youth crime. Additionally, it will likely highlight significant trends in risk and protective factors, such as the dual role of academic achievement—both as a risk and protective factor—and the impact of family-based interventions. …”

Digital Microfluidic Platform Based on Printed Circuit Board for Affinity Evaluation of Mertansine Aptamers by Dongliu Xiang (10688647)

“…Compared with manual methods, the digital microfluidic platform not only reduced the time for a single determination from 105 to 45 min but also significantly decreased the reagent consumption from 1280 to 30.72 μL. …”

GrowSafe™ system and steer eating. by M. Jordana Rivero (14610947)

Subjects:

Definitions of the key terms used in this study. by Eriko Takahashi (22608061)

Subjects:

Excluded skewed studies. by Solima Sabeel (9545738)

Subjects:

Structural equation modeling results of each self-compassion model. by Eriko Takahashi (22608061)

Subjects:

Weather conditions throughout the study period. by M. Jordana Rivero (14610947)

Subjects:

Summary of correlations regarding six-factor self-compassion. by Eriko Takahashi (22608061)

Subjects:

Frequency of trough visits throughout the day. by M. Jordana Rivero (14610947)

Subjects:

Stratified meta-analysis for treatment duration effects of statins versus placebo subdivided into 3-4 months and longer than 4 months of treatment for by Solima Sabeel (9545738)

Subjects:

Reason for exclusion of all 6514 screened articles. by Solima Sabeel (9545738)

Subjects: